Scott Jones
Corporate Officer/Principal presso EYEPOINT PHARMACEUTICALS, INC.
Patrimonio netto: 928 414 $ in data 31/03/2024
Profilo
Scott Jones is currently the Chief Commercial Officer & Senior Vice President at EyePoint Pharmaceuticals, Inc. He previously worked as the Executive Director-Health Policy at Novartis Pharmaceuticals Corp.
from 2006 to 2009, as the Executive Director & Head-Market Access at Novartis Ophthalmics, Inc. from 2004 to 2006, as the President at QLT Ophthalmics, Inc. from 2009 to 2013, and as the Chief Commercial Officer & VP-Business Development at Notal Vision, Inc. from 2013 to 2019.
Mr. Jones received his undergraduate and graduate degrees from the University of Florida.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
09/02/2024 | 44 916 ( 0.09% ) | 928 414 $ | 31/03/2024 |
Posizioni attive di Scott Jones
Società | Posizione | Inizio |
---|---|---|
EYEPOINT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 10/06/2019 |
Precedenti posizioni note di Scott Jones
Società | Posizione | Fine |
---|---|---|
Notal Vision, Inc.
Notal Vision, Inc. Medical SpecialtiesHealth Technology Part of Notal Vision Ltd., Notal Vision, Inc. develops ophthalmic diagnostic devices. The private company is based in Manassas, VA. The company was founded by Barak Azmon. The CEO is Kester Nahen. | Corporate Officer/Principal | 01/06/2019 |
QLT Ophthalmics, Inc. | President | 01/01/2013 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2009 |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Director/Board Member | 01/01/2006 |
Formazione di Scott Jones
University of Florida | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
QLT Ophthalmics, Inc. | |
Notal Vision, Inc.
Notal Vision, Inc. Medical SpecialtiesHealth Technology Part of Notal Vision Ltd., Notal Vision, Inc. develops ophthalmic diagnostic devices. The private company is based in Manassas, VA. The company was founded by Barak Azmon. The CEO is Kester Nahen. | Health Technology |
- Borsa valori
- Insiders
- Scott Jones